Results
|
4121.
|
Functional characterization of human UDP-glucuronosyltransferase 1A9 variant, D256N, found in Japanese cancer patients. [electronic resource] by
- Jinno, Hideto
- Saeki, Mayumi
- Saito, Yoshiro
- Tanaka-Kagawa, Toshiko
- Hanioka, Nobumitsu
- Sai, Kimie
- Kaniwa, Nahoko
- Ando, Masanori
- Shirao, Kuniaki
- Minami, Hironobu
- Ohtsu, Atsushi
- Yoshida, Teruhiko
- Saijo, Nagahiro
- Ozawa, Shogo
- Sawada, Jun-ichi
Producer: 20030828
In:
The Journal of pharmacology and experimental therapeutics vol. 306
Availability: No items available.
|
|
4122.
|
|
|
4123.
|
|
|
4124.
|
Salvage chemotherapy with mitomycin, docetaxel, and irinotecan (MDI regimen) in metastatic pancreatic adenocarcinoma: a phase I and II trial. [electronic resource] by
- Reni, Michele
- Panucci, M G
- Passoni, P
- Bonetto, E
- Nicoletti, R
- Ronzoni, M
- Zerbi, A
- Staudacher, C
- Di Carlo, V
- Villa, E
Producer: 20041229
In:
Cancer investigation vol. 22
Availability: No items available.
|
|
4125.
|
Low overexpression of HER-2/neu in advanced colorectal cancer limits the usefulness of trastuzumab (Herceptin) and irinotecan as therapy. A phase II trial. [electronic resource] by
- Ramanathan, Ramesh K
- Hwang, Jimmy J
- Zamboni, William C
- Sinicrope, Frank A
- Safran, Howard
- Wong, Michael K
- Earle, Martin
- Brufsky, Adam
- Evans, Terry
- Troetschel, Monica
- Walko, Christine
- Day, Roger
- Chen, Helen X
- Finkelstein, Sydney
Producer: 20050203
In:
Cancer investigation vol. 22
Availability: No items available.
|
|
4126.
|
|
|
4127.
|
Phase I/II study of irinotecan (CPT-11) and S-1 in the treatment of advanced gastric cancer. [electronic resource] by
- Katsube, Takao
- Ogawa, Kenji
- Ichikawa, Wataru
- Fujii, Masashi
- Tokunaga, Akira
- Takagi, Yuh
- Kochi, Misugu
- Hayashi, Kazuhiko
- Kubota, Tetsuro
- Aiba, Keisuke
- Arai, Kuniyoshi
- Terashima, Masanori
- Kitajima, Masaki
Producer: 20070522
In:
Anti-cancer drugs vol. 18
Availability: No items available.
|
|
4128.
|
|
|
4129.
|
|
|
4130.
|
|
|
4131.
|
|
|
4132.
|
Intra and inter-molecular interactions dictate the aggregation state of irinotecan co-encapsulated with floxuridine inside liposomes. [electronic resource] by
- Dicko, Awa
- Frazier, April A
- Liboiron, Barry D
- Hinderliter, Anne
- Ellena, Jeff F
- Xie, Xiaowei
- Cho, Connie
- Weber, Tom
- Tardi, Paul G
- Cabral-Lilly, Donna
- Cafiso, David S
- Mayer, Lawrence D
Producer: 20080829
In:
Pharmaceutical research vol. 25
Availability: No items available.
|
|
4133.
|
|
|
4134.
|
Antiemetic control with palonosetron in patients with gastrointestinal cancer receiving a fluoropyrimidine-based regimen in addition to either irinotecan or oxaliplatin: a retrospective study. [electronic resource] by
- Blazer, Marlo
- Phillips, Gary
- Reardon, Joshua
- Efries, David
- Smith, Yahna
- Weatherby, Lynn
- Juergens, Kim
- Rose, Jeffrey
- Griffith, Niesha
- Bekaii-Saab, Tanios
Producer: 20121030
In:
Oncology vol. 83
Availability: No items available.
|
|
4135.
|
|
|
4136.
|
|
|
4137.
|
Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C89803. [electronic resource] by
- Sargent, D
- Shi, Q
- Yothers, G
- Van Cutsem, E
- Cassidy, J
- Saltz, L
- Wolmark, N
- Bot, B
- Grothey, A
- Buyse, M
- de Gramont, A
Producer: 20111115
In:
European journal of cancer (Oxford, England : 1990) vol. 47
Availability: No items available.
|
|
4138.
|
A pilot study of adjuvant chemotherapy with irinotecan and cisplatin for completely resected high-grade pulmonary neuroendocrine carcinoma (large cell neuroendocrine carcinoma and small cell lung cancer). [electronic resource] by
- Kenmotsu, Hirotsugu
- Niho, Seiji
- Ito, Takeo
- Ishikawa, Yuichi
- Noguchi, Masayuki
- Tada, Hirohito
- Sekine, Ikuo
- Watanabe, Shun-Ichi
- Yoshimura, Masahiro
- Yamamoto, Nobuyuki
- Oshita, Fumihiro
- Kubota, Kaoru
- Nagai, Kanji
Producer: 20150121
In:
Lung cancer (Amsterdam, Netherlands) vol. 84
Availability: No items available.
|
|
4139.
|
|
|
4140.
|
Hepatic activation of irinotecan predicts tumour response in patients with colorectal liver metastases treated with DEBIRI: exploratory findings from a phase II study. [electronic resource] by
- Jones, R P
- Sutton, P
- Greensmith, R M D
- Santoyo-Castelazo, A
- Carr, D F
- Jenkins, R
- Rowe, C
- Hamlett, J
- Park, B K
- Terlizzo, M
- O'Grady, E
- Ghaneh, P
- Fenwick, S W
- Malik, H Z
- Poston, G J
- Kitteringham, N R
Producer: 20130924
In:
Cancer chemotherapy and pharmacology vol. 72
Availability: No items available.
|